NCT03810729 (iRADIAL-CABG) is a NA clinical trial of Smartphone assessment in Coronary Artery Disease, sponsored by Ottawa Heart Institute Research Corporation.

Who is sponsoring NCT03810729?

NCT03810729 is sponsored by Ottawa Heart Institute Research Corporation.

What drugs are being tested in NCT03810729?

Interventions in NCT03810729: Smartphone assessment, Modified Allen's Test.

What condition does NCT03810729 study?

NCT03810729 studies Coronary Artery Disease.

Is NCT03810729 still recruiting?

NCT03810729 is currently completed. Last updated 12 October 2022.

Last reviewed 2022-10-12 · How we verify

NCT03810729: iRADIAL-CABG

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Smartphone Assessment Prior Radial Artery Harvesting for CABG

Completed NA Last updated 12 October 2022

What this trial tests

NA trial testing Smartphone assessment in Coronary Artery Disease in 236 participants. Completed in 8 August 2022.

Timeline

15 May 2019

Primary endpoint
8 August 2022

8 August 2022

Quick facts

Lead sponsor	Ottawa Heart Institute Research Corporation
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	screening
Enrollment	236
Start date	15 May 2019
Primary completion	8 August 2022
Estimated completion	8 August 2022
Sites	1 location across Canada

Drugs / interventions tested

Smartphone assessment
Modified Allen's Test

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

Ottawa Heart Institute Research Corporation

Who can join

18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Coronary artery bypass graft (CABG) surgery is a procedure where surgeons use blood vessels from elsewhere in the body to go around blockages or narrowings in the heart arteries. Before the surgery, the surgeon needs to choose which vessel will be used for the bypass, including potentially the radial artery in the wrist. Smartphones have been shown in a previous study to be a better way to assess the arteries in the hand than the traditional physical examination, as it is less subjective than simply watching the flushing of the hand. In this study, the investigators will assess the utility of a smartphone application in determining whether there is enough blood flow in the hand prior to using the radial artery for CABG surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Utility of a smartphone application in assessing palmar circulation prior to radial artery harvesting for coronary artery bypass grafting: rationale and design of the randomised CAPITAL iRADIAL-CABG trial.
Goh CY, Parlow S, Di Santo P, Simard T, et al · · 2022 · cited 2× · PMID 35396289 · DOI 10.1136/bmjopen-2021-055580

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Ottawa Heart Institute Research Corporation trials

Trials by the same sponsor.

NCT06907251 — Dapagliflozin for Long COVID Syndrome · Phase 3 · not yet recruiting
NCT07002450 — Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Departm · NA · recruiting
NCT06832085 — Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation · Phase 4 · recruiting
NCT06556667 — MAX - SHOCK Clinical Trial · NA · recruiting
NCT06816888 — Impact of Automatic Prompts in Echocardiographic Reports on Referral to Cardiology · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03810729 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ottawa Heart Institute Research Corporation
Last refreshed: 12 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03810729.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing